VOTIS

Jerusalem, Israel Founded: 2017 • Age: 9 yrs
AI-based device and platform for diagnosing diabetic patient feet

About VOTIS

VOTIS is a company based in Jerusalem (Israel) founded in 2017.. VOTIS has raised $4.77 million across 4 funding rounds from investors including European Union, Italian Angels for Growth and MassChallenge. VOTIS offers products and services including PedCheck, PedStage, and PedFlo. VOTIS operates in a competitive market with competitors including Podimetrics, Thermetrix, Mimosa Diagnostics, Pedra and Celsius Health, among others.

  • Headquarter Jerusalem, Israel
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Votis Subdermal Imaging Technologies Ltd.
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $4.77 M (USD)

    in 4 rounds

  • Latest Funding Round
    $2.27 M (USD), Seed

    Apr 21, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of VOTIS

VOTIS offers a comprehensive portfolio of products and services, including PedCheck, PedStage, and PedFlo. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Screens for peripheral artery disease in diabetic patients.

Evaluates blood flow and ulcer severity in foot conditions.

Assesses blood flow during surgical procedures.

People of VOTIS
Headcount 1-10
Employee Profiles 8
Employee Profiles
People
Eliyahushalom Kolet
Physics And Systems Engineer
People
Merrill Weber
Co-Founder, CEO, and President
People
Mashiach Hakimi
Chief Product Officer
People
Ariel Rachminov
System Engineer

Unlock access to complete

Funding Insights of VOTIS

VOTIS has successfully raised a total of $4.77M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $2.27 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Seed — $2.3M
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2023 Amount Seed - VOTIS Valuation Italian Angels for Growth
Jun, 2021 Amount Seed - VOTIS Valuation

investors

Aug, 2019 Amount Grant - VOTIS Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in VOTIS

VOTIS has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Italian Angels for Growth and MassChallenge. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
A network of business angels is formed to support innovative startups.
Founded Year Domain Location
Early-stage entrepreneurs are accelerated through MassChallenge's program.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by VOTIS

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - VOTIS

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Votis Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of VOTIS

VOTIS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Podimetrics, Thermetrix, Mimosa Diagnostics, Pedra and Celsius Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of diabetic foot ulcer monitoring device for patients and doctors
domain founded_year HQ Location
Medical device design and development company
domain founded_year HQ Location
Early foot ulcer detection is facilitated by non-invasive mHealth technology.
domain founded_year HQ Location
Tissue perfusion monitoring technology for medical diagnostics is developed.
domain founded_year HQ Location
Develops innovative devices for managing diabetic foot ulcers.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Votis

Frequently Asked Questions about VOTIS

When was VOTIS founded?

VOTIS was founded in 2017.

Where is VOTIS located?

VOTIS is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.

Is VOTIS a funded company?

VOTIS is a funded company, having raised a total of $4.77M across 4 funding rounds to date. The company's 1st funding round was a Grant of $55.39K, raised on May 23, 2017.

What does VOTIS do?

AI-based device and platform for diagnosing diabetic patient feet. The device uses infrared and near-infrared light to screen the feet for wounds, infection, and foot ischemia in the diabetic foot. The data is recorded on the cloud platform and assessed using proprietary algorithms. The AI and ML technology provide 3-dimensional maps describing physiological parameters within the foot and provide the prognosis. The disease is monitored for progress in treatment and also the data can be shared with the doctors.

Who are the top competitors of VOTIS?

VOTIS's top competitors include Podimetrics, Pedra and Mimosa Diagnostics.

What products or services does VOTIS offer?

VOTIS offers PedCheck, PedStage, and PedFlo.

Who are VOTIS's investors?

VOTIS has 3 investors. Key investors include European Union, Italian Angels for Growth, and MassChallenge.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available